Australia’s medicinal cannabis sector is evolving and so are patient expectations.

With patients becoming more informed, more selective, and more willing to change providers if their experience doesn’t meet expectations.In our latest blog, Medicinal Cannabis Patients: Preferences & Perspectives, we explore what patients actually value today and the trends clinics should be preparing for as the market continues to mature.

Whether you're a clinic operator, healthcare professional, or industry stakeholder, understanding these shifts is key to building sustainable, patient-centred care models.

Understanding the patient pathway to medicinal cannabis in Australia can be a major hurdle for businesses . 
Our latest blog post breaks down the entire journey from clinical assessment to TGA approval, highlighting the critical operational frameworks businesses need to support Australian patients effectively.

This article explores the role of pharmacists in dispensing medicinal cannabis, with a focus on patient access, continuity of care, and quality oversight.

For businesses looking to enter or maximise their presence within the medicinal cannabis market, understanding the evolving prescriber landscape and access pathways is crucial to navigate this dynamic market effectively.

Since its legalisation for therapeutic use, Australia’s medicinal cannabis industry has rapidly evolved, marked by complex regulatory changes and a growing infrastructure — making it essential for industry stakeholders to understand the journey of legalisation, its impact on Australian patients, and the diverse ecosystem of stakeholders working to expand access and challenge the lingering stigma surrounding medicinal cannabis.

For healthcare practitioners prescribing or dispensing medicinal cannabis in Australia, it’s essential to understand the varying regulations that can impact patient outcomes — including dispensing substitution policies for these medications.